Migraine and Altitude: Why High Elevation Increases Attack Risk

Altitude is a migraine trigger that surprises many people who associate their attacks with more familiar precipitants like stress, poor sleep, or certain foods. Yet for people who are susceptible, travel to high-altitude destinations — mountain resorts, cities above five thousand feet, or trekking routes — can reliably trigger migraine attacks that do not occur at lower elevations. Understanding why altitude affects the migraine nervous system provides a basis for preparation and management that allows altitude-sensitive people with migraine to travel and recreate in high-elevation environments more safely.

The Physiology of Altitude

As altitude increases, atmospheric pressure decreases, and with it the partial pressure of oxygen in the air. At sea level, atmospheric pressure is approximately seven hundred and sixty millimeters of mercury and oxygen partial pressure is approximately one hundred and sixty millimeters. At ten thousand feet, atmospheric pressure drops to approximately five hundred and twenty millimeters and oxygen partial pressure falls proportionally. The result is that each breath contains less oxygen, and the body must compensate through increased breathing rate, increased cardiac output, and over days to weeks through acclimatization.

Hypoxia and the Migraine Nervous System

The reduced oxygen availability at altitude creates a state of mild hypoxia that has direct effects on the migraine nervous system. Hypoxia is a potent stimulus for cerebral vasodilation — the brain responds to reduced oxygen delivery by dilating cerebral blood vessels to increase blood flow and oxygen supply. This cerebral vasodilation is the same mechanism involved in migraine pain generation, and in people with migraine susceptibility it may directly activate the trigeminovascular system.

Carbon dioxide also plays a role. The increased breathing rate that accompanies altitude exposure reduces carbon dioxide levels in the blood, producing hypocapnia. Hypocapnia causes cerebral vasoconstriction, which can paradoxically worsen the hypoxic state and create oscillating vascular changes that may trigger the trigeminovascular cascade in susceptible individuals.

Altitude Sickness and Migraine

Acute mountain sickness, which affects many people who ascend rapidly to altitudes above eight thousand feet without acclimatization, is characterized by headache as its defining symptom alongside nausea, fatigue, and dizziness. The headache of acute mountain sickness shares characteristics with migraine, and people with migraine may experience more severe headache at altitude than people without migraine.

Barometric Pressure and Altitude

The barometric pressure drop that accompanies altitude ascent is the same trigger variable documented in weather-related migraine research. For people who have identified barometric pressure changes as a personal migraine trigger, ascending to high altitude represents a sustained large-magnitude pressure drop rather than the transient pressure changes of passing weather systems.

Practical Management at Altitude

Gradual ascent with acclimatization days built into the schedule allows the body to adapt to altitude before reaching the highest elevation. Acetazolamide, a medication commonly used for altitude sickness prevention, works partly by reducing the hypocapnia response to altitude and may reduce both altitude sickness and altitude-triggered migraine. Ensuring adequate hydration at altitude addresses the compounding dehydration that worsens altitude effects. Discussing altitude travel plans with a healthcare provider before departure allows for individualized advice on whether acetazolamide or adjustments to migraine medications are appropriate.